{"count":3,"index":{"built_at":"2026-07-27T13:40:04.459396+00:00","public_records":55311,"revision":"c7bb05c11a1ac7217db1a8fb"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: VKORC1 in the context of longevity"},"results":[{"answer":"The provided context contains no specific data or studies on VKORC1 in relation to longevity. VKORC1 encodes vitamin K epoxide reductase, a key enzyme in the vitamin K cycle, best known for its role in warfarin sensitivity. In longevity research, vitamin K is increasingly discussed for its role in activating matrix Gla protein (MGP) and inhibiting vascular calcification – a potential mechanism for cardiovascular health in aging. However, these links are based mostly on mechanistic and epidemiological data; robust GWAS or interventional studies directly associating VKORC1 variants with extended lifespan are lacking. The evidence is therefore rated as 'mechanistic' to 'unclear'. Without concrete lab results or clinical trials from the context, any claim remains speculative. Consumers should be aware that DNA tests for VKORC1 are primarily validated for pharmacogenetics (warfarin dosing), not for longevity prediction. Lifestyle factors (diet, exercise, stress management) currently have a far greater impact on healthy lifespan than single gene variants.","area":"gesundheit","canonical_id":"gesundheit:canonical-04206a6cb5e365240e02e5b3","id":"public-54503b820f384cc4b9ba6b3d","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: VKORC1 in the context of longevity","score":24.34218661,"snippet":"The provided context contains no specific data or studies on VKORC1 in relation to longevity. VKORC1 encodes vitamin K epoxide reductase, a key enzyme in the vitamin K cycle, best known for its role in warfarin sensitivity. In longevity research, vitamin K is increasingly discussed for its role in activating matrix Gla protein (MGP) and inhibiting vascular calcification – a potential mechanism for cardiovascular health in aging. However, these links are based mostly on mechanistic and epidemiological data; robust GWAS or interventional studies directly associating VKORC1 variants with extended lifespan are lacking. The evidence is therefore rated as 'mechanistic' to 'unclear'. Without concre","sources":[],"title":"Evidence check: VKORC1 in the context of longevity","url":"https://tikki.wiki/wissen/gesundheit/frage/public-54503b820f384cc4b9ba6b3d/evidence-check-vkorc1-in-the-context-of-longevity/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"VKORC1 encodes the vitamin K epoxide reductase, crucial for recycling vitamin K, which activates proteins involved in blood coagulation and vascular calcification. In longevity research, VKORC1 is indirectly relevant: adequate vitamin K status supports arterial elasticity and bone health, both linked to healthy aging. However, the strongest evidence for VKORC1 variants comes from pharmacogenetics (warfarin sensitivity), not from lifespan studies. Common SNPs like rs9923231 and rs7294 alter enzyme activity and may modulate vitamin K requirements, but their impact on longevity is unclear and likely small. Observational studies suggest associations with cardiovascular calcification, but no direct GWAS or centenarian data confirm a role in extending lifespan. Therefore, a consumer DNA test for VKORC1 alone cannot predict longevity. Evidence grade: mechanistic/unclear. Caveat: Do not self-supplement high-dose vitamin K without medical guidance, especially if on anticoagulants.","area":"gesundheit","canonical_id":"gesundheit:canonical-7032b09abb46347af336ada3","id":"public-b8cecccb1fb947117b470d0e","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: VKORC1 in the context of Langlebigkeit","score":23.98736204,"snippet":"VKORC1 encodes the vitamin K epoxide reductase, crucial for recycling vitamin K, which activates proteins involved in blood coagulation and vascular calcification. In longevity research, VKORC1 is indirectly relevant: adequate vitamin K status supports arterial elasticity and bone health, both linked to healthy aging. However, the strongest evidence for VKORC1 variants comes from pharmacogenetics (warfarin sensitivity), not from lifespan studies. Common SNPs like rs9923231 and rs7294 alter enzyme activity and may modulate vitamin K requirements, but their impact on longevity is unclear and likely small. Observational studies suggest associations with cardiovascular calcification, but no dire","sources":[],"title":"Evidence check: VKORC1 in the context of Langlebigkeit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-b8cecccb1fb947117b470d0e/evidence-check-vkorc1-in-the-context-of-langlebigkeit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The combination of a Cardio Risk Check and menopause is not directly addressed in the provided context. The available information covers pharmacogenetics (CYP2D6, CYP2C19, VKORC1), hormone tests (without specifying cardiovascular markers), and microbiome/longevity tests. It is well established that menopause increases cardiovascular risk due to estrogen decline, but a consumer DNA or biomarker test alone cannot comprehensively assess this risk. Evidence for such tests in this specific context is unclear – there are no clinically validated studies demonstrating direct benefit. A proper Cardio Risk Check should incorporate traditional risk factors (blood pressure, lipids, glucose, smoking, family history) alongside menopausal status. Without integration into a clinical framework, the test's value remains limited. Safety note: Do not rely solely on a consumer genetic test for cardiovascular risk assessment during menopause; consult a healthcare provider.","area":"gesundheit","canonical_id":"gesundheit:canonical-ccbfaab7adb4f3d36ade19ed","id":"public-c55149e2ad24f5be7e24dcab","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Cardio Risk Check in the context of menopause","score":21.16849062,"snippet":"The combination of a Cardio Risk Check and menopause is not directly addressed in the provided context. The available information covers pharmacogenetics (CYP2D6, CYP2C19, VKORC1), hormone tests (without specifying cardiovascular markers), and microbiome/longevity tests. It is well established that menopause increases cardiovascular risk due to estrogen decline, but a consumer DNA or biomarker test alone cannot comprehensively assess this risk. Evidence for such tests in this specific context is unclear – there are no clinically validated studies demonstrating direct benefit. A proper Cardio Risk Check should incorporate traditional risk factors (blood pressure, lipids, glucose, smoking, fam","sources":[],"title":"Evidence check: Cardio Risk Check in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-c55149e2ad24f5be7e24dcab/evidence-check-cardio-risk-check-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}